Navidea Biopharmaceuticals Announces Results from Lymphoseek® Study on Accuracy of Lymph Node Detection from Injection ... Navidea Biopharmaceuticals, Inc. , a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced positive results from a meta-analysis study of Lymphoseek® Injection that compared the performance of Lymphoseek, a novel, receptor-targeted radiopharmaceutical recently approved by the U.S.
June 11, 2013 - Business Wire via Yahoo! Finance
Navidea Biopharmaceuticals Announces Presentation of Results from Two Lymphoseek® and Radiolabeled Colloid Studies in ... Navidea Biopharmaceuticals, Inc. , a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced results from two separate studies that compared the performance of Lymphoseek® Injection, a novel receptor-targeted small-molecule radiopharmaceutical recently approved by the U.S.
June 10, 2013 - Business Wire via Yahoo! Finance